Volume 27, issue 4, Juillet-Août 2021

SFH 2021

ADAMTS13 structure and anti-ADAMTS13 autoantibodies in immune mediated Thrombotic Thrombocytopenic Purpura (p.153-5)

Autotemcel betiblogene gene therapy for the treatment of transfusion-dependent β-thalassemia: update of long-term efficacy and safety results (p.157-8)

Acute Myeloid Leukaemia (p.160-1)

SFH 2021 (p.163-71)

Open Access

Revues

Sickle cell disease and risk of haematological malignancies (p.173-87)
Françoise Bernaudin, Mathieu Kuentz, Yves Beuzard

News in thrombotic thrombocytopenic purpura and ADAMTS13 (p.188-99)
Bérangère Joly, Nicolas Beranger, Ygal Benhamou, Paul Coppo, Agnès Veyradier

Neutrophil extracellular traps: key drivers of severe Covid-19 (p.200-7)
Cécile Oury, Thomas Marichal